HBK Sorce Advisory’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,275
| Closed | -$285K | – | 630 |
|
|
2025
Q1 | $285K | Sell |
1,275
-22
| -2% | -$4.93K | 0.01% | 463 |
|
|
2024
Q4 | $425K | Sell |
1,297
-11
| -0.8% | -$3.6K | 0.01% | 372 |
|
|
2024
Q3 | $393K | Buy |
1,308
+292
| +29% | +$87.6K | 0.01% | 397 |
|
|
2024
Q2 | $335K | Sell |
1,016
-25
| -2% | -$8.24K | 0.01% | 414 |
|
|
2024
Q1 | $412K | Sell |
1,041
-712
| -41% | -$282K | 0.01% | 385 |
|
|
2023
Q4 | $617K | Sell |
1,753
-32
| -2% | -$11.3K | 0.02% | 278 |
|
|
2023
Q3 | $670K | Sell |
1,785
-11
| -0.6% | -$4.13K | 0.03% | 255 |
|
|
2023
Q2 | $687K | Sell |
1,796
-91
| -5% | -$34.8K | 0.03% | 262 |
|
|
2023
Q1 | $654K | Sell |
1,887
-2,085
| -52% | -$722K | 0.03% | 280 |
|
|
2022
Q4 | $935K | Buy |
3,972
+2,739
| +222% | +$645K | 0.03% | 300 |
|
|
2022
Q3 | $303K | Buy |
1,233
+28
| +2% | +$6.88K | 0.02% | 364 |
|
|
2022
Q2 | $364K | Buy |
1,205
+177
| +17% | +$53.5K | 0.03% | 297 |
|
|
2022
Q1 | $422K | Sell |
1,028
-42
| -4% | -$17.2K | 0.02% | 327 |
|
|
2021
Q4 | $502K | Buy |
1,070
+43
| +4% | +$20.2K | 0.03% | 328 |
|
|
2021
Q3 | $436K | Buy |
1,027
+53
| +5% | +$22.5K | 0.02% | 348 |
|
|
2021
Q2 | $350K | Sell |
974
-27
| -3% | -$9.7K | 0.02% | 412 |
|
|
2021
Q1 | $282K | Buy |
1,001
+106
| +12% | +$29.9K | 0.02% | 412 |
|
|
2020
Q4 | $254K | Buy |
895
+109
| +14% | +$30.9K | 0.02% | 420 |
|
|
2020
Q3 | $216K | Buy |
+786
| New | +$216K | 0.02% | 408 |
|